Gene: ERFE
Official Full Name: erythroferroneprovided by HGNC
Gene Summary: Predicted to enable hormone activity. Predicted to be involved in several processes, including negative regulation of metabolic process; negative regulation of osteoblast differentiation; and positive regulation of signal transduction. Predicted to act upstream of or within positive regulation of fatty acid transport and regulation of fatty acid metabolic process. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22005 | ERFE Knockout cell line (HCT 116) | Human | ERFE | 1:2~1:4 | Negative | Online Inquiry |
KO22006 | ERFE Knockout cell line (HEK293) | Human | ERFE | 1:3~1:6 | Negative | Online Inquiry |
KO22007 | ERFE Knockout cell line (A549) | Human | ERFE | 1:3~1:4 | Negative | Online Inquiry |
ERFE Gene Knockout Cell Lines are genetically engineered cell models specifically designed to ablate the expression of the erythroferrone (ERFE) gene. ERFE plays a crucial role in regulating iron metabolism by inhibiting hepcidin, the liver hormone that controls the absorption and recycling of iron. The knockout of ERFE facilitates the study of iron homeostasis, erythropoiesis, and pathologies related to iron overload or deficiency.
These cell lines function by utilizing CRISPR-Cas9 technology to create precise mutations that disrupt the ERFE gene, thereby producing models that lack functional ERFE protein. Researchers can manipulate these knockout lines to explore cellular responses to altered iron levels, assess erythroid differentiation, and evaluate the impact on related signaling pathways. This capability offers profound insights into diseases such as anemia of chronic disease or hereditary hemochromatosis, where dysregulation of iron homeostasis is evidenced.
The scientific importance of ERFE Gene Knockout Cell Lines cannot be overstated. They serve as vital tools in contemporary biomedical research, providing robust models for testing potential therapies that target iron regulation, and advancing the understanding of iron-related disorders in clinical settings. Compared to traditional models, these knockout lines offer higher specificity and accuracy, reducing off-target effects and yielding clearer experimental results.
What sets ERFE Gene Knockout Cell Lines apart from alternatives is the combination of precision gene editing and their broad application potential in both basic and translational research. These models empower researchers to design more impactful studies, ultimately contributing to the development of novel treatments and improving patient outcomes.
At the forefront of biotechnological innovation, our company specializes in the provision of high-quality genetic models, ensuring that researchers and clinicians have access to the most advanced tools necessary for their work in understanding complex biological systems. We are committed to supporting scientific discovery through our comprehensive array of customizable biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.